Immunogenicity of the whole antigen and glycoprotein I of Varicella-zoster virus (VZV) and the VZV skin test antigen

被引：0
|
作者：
Kawano, S
Terada, K
Hiraga, Y
Morita, T
机构：
来源：
ACTA PAEDIATRICA JAPONICA | 1996年 / 38卷 / 02期
关键词：
glycoprotein I; immunogenicity; skin test antigen; varicella-zoster virus;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Specific cellular immunity against the whole antigen and glycoprotein I (gp I) of varicella-zoster virus (VZV) and the skin test antigen were determined for 13 healthy immune adults to compare the immunogenicity of these antigens using a lymphoproliferative assay. The stimulation index values (mean +/- s.d.) were 16.4 +/- 11.2 against the whole VZV antigen, 4.2 +/- 2.9 against the VZV skin test antigen and 1.1 +/- 0.5 against gp I. The immunogenicity of the skin test antigen, which mainly contains gp III and gp IV, appears to be more favorable than that of gp I alone, but to be weaker than that of the whole VZV antigen.
引用
收藏
页码：121 / 123
页数：3
相关论文
共 50 条
  • [1] SAFETY AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS (VZV) VACCINE IN ADULTS
    KUMAR, ML
    COLLINS, MS
    GOPALAKRISHNA, KV
    [J]. PEDIATRIC RESEARCH, 1986, 20 (04) : A313 - A313
  • [2] Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction
    Takahashi, M
    Kamiya, H
    Asano, Y
    Shiraki, K
    Baba, K
    Otsuka, T
    Hirota, T
    Yamanishi, K
    [J]. IMMUNITY TO AND PREVENTION OF HERPES ZOSTER, 2001, 17 : 161 - 172
  • [3] ACTIVATION OF LYMPHOCYTES BY VARICELLA-ZOSTER VIRUS (VZV) - EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON LYMPHOCYTES CULTURED WITH VZV ANTIGEN
    ITO, M
    NAKANO, T
    KAMIYA, T
    KITAMURA, K
    KOMADA, Y
    IHARA, T
    KAMIYA, H
    SAKURAI, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01): : 158 - 161
  • [4] Vaccines against varicella-zoster virus (VZV)
    Salleras, Luis
    Salleras, Montserrat
    Soldevila, Nuria
    Prat, Andreu
    Garrido, Patricio
    Dominguez, Angela
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (06): : 411 - 423
  • [5] SENSITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR ANTIBODY TO VARICELLA-ZOSTER VIRUS USING PURIFIED VZV GLYCOPROTEIN ANTIGEN
    WASMUTH, EH
    MILLER, WJ
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (03) : 189 - 193
  • [6] Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids
    Mallory, S
    Sommer, M
    Arvin, AM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 : S22 - S26
  • [7] INHIBITION OF VARICELLA-ZOSTER VIRUS (VZV) GLYCOPROTEIN EXPRESSION BY A HUMAN MONOCLONAL-ANTIBODY AGAINST VZV GLYCOPROTEIN-III
    ITO, M
    MIZUTANI, K
    KAMIYA, T
    IHARA, T
    KAMIYA, H
    SAKURAI, M
    SUGANO, T
    MATUMOTO, Y
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (05): : 1256 - 1259
  • [8] Issues in varicella-zoster virus (VZV) ganglionic latency
    Kennedy, Peter G.
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 : 38 - 39
  • [9] Seroprevalence of varicella-zoster virus (VZV) in the French population
    Debruyne, M
    Floret, D
    Khoshnood, B
    Emery, C
    Fagnani, F
    Lancon, F
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S240 - S240
  • [10] Varicella-zoster virus (VZV) DNA in serum of patients with VZV central nervous system infections
    Grahn, Anna
    Bergstrom, Tomas
    Runesson, Jim
    Studahl, Marie
    [J]. JOURNAL OF INFECTION, 2016, 73 (03) : 254 - 260
12345